4th Quarter - Report

CAPITOL COUNSEL LLC for GENENTECH

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Monitor implementation of Medicare pharmaceutical coverage and reimbursement provisions of P.L. 111-148 - Patient Protection and Affordable Care Act and P.L. 111-152 - Health Care and Education Reconciliation Act.

Foreign entity interest: Foreign parent company affected by policies that affect Genentech in the U.S.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Monitoring proposals on U.S. tax treatment of foreign corporations; S. 506, Stop Tax Haven Abuse Act

Foreign entity interest: Foreign parent company affected by policies that affect Genentech in the U.S.

LobbyistCovered position, as disclosed
SHANNON FINLEY —
JAMES GOULD —
JAMES O MCCRERY —
JOHN D RAFFAELLI —
TUCKER SHUMACK —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 506 (111th)

Health Issues HCR

Monitor changes to outpatient 340B prescription drug discount program, including related provisions included in HR 4994, Medicare & Medicaid Extenders Act.

Foreign entity interest: Foreign parent company affected by policies that affect Genentech in the U.S.

LobbyistCovered position, as disclosed
CATHERINE FINLEY —
SHANNON FINLEY —
SARA FRANKO —
DREW GOESL —
JAMES GOULD —
DENISE HENRY MORRISEY —
JAMES O MCCRERY —
JOHN D RAFFAELLI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4994 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.